dQM QICore Content Implementation Guide
2025.0.0 - CI Build
dQM QICore Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2025.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-qicore-2025/ and changes regularly. See the Directory of published versions
Official URL: https://madie.cms.gov/Measure/CMS129FHIRProstCaBoneScanUse | Version: 1.0.000 | |||
Active as of 2025-08-21 | Responsible: Centers for Medicare & Medicaid Services (CMS) | Computable Name: CMS129FHIRProstCaBoneScanUse | ||
Other Identifiers: Short Name: CMS129FHIR (use: usual, ), UUID:a9fa2b95-f5f7-4ff4-931c-b47df9d6371f (use: official, ), UUID:2bdfa3ee-eaa5-42ae-8483-a71dc6d3521f (use: official, ), Publisher: 129FHIR (use: official, ) | ||||
Copyright/Legal: This electronic clinical quality measure (Measure) and related data specifications are owned and stewarded by the Centers for Medicare \& Medicaid Services (CMS). CMS contracted (Contract # 75FCMC18D0027/ Task Order #: 75FCMC24F0144) with the American Institutes for Research (AIR) to develop this electronic measure. AIR is not responsible for any use of the Measure. AIR makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and AIR has no liability to anyone who relies on such measures or specifications. Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. AIR disclaims all liability for use or accuracy of any third-party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2023 American Medical Association. LOINC(R) is copyright 2004-2023 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2023 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2023 World Health Organization. All Rights Reserved. |
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer
Metadata | |
---|---|
Title | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer PatientsFHIR |
Version | 1.0.000 |
Short Name | CMS129FHIR |
GUID (Version Independent) | urn:uuid:a9fa2b95-f5f7-4ff4-931c-b47df9d6371f |
GUID (Version Specific) | urn:uuid:2bdfa3ee-eaa5-42ae-8483-a71dc6d3521f |
CMS Identifier | 129FHIR |
Effective Period | 2026-01-01 through 2026-12-31 |
Steward (Publisher) | Centers for Medicare & Medicaid Services (CMS) |
Developer | American Institutes for Research (AIR) |
Description | Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer |
Copyright | This electronic clinical quality measure (Measure) and related data specifications are owned and stewarded by the Centers for Medicare & Medicaid Services (CMS). CMS contracted (Contract # 75FCMC18D0027/ Task Order #: 75FCMC24F0144) with the American Institutes for Research (AIR) to develop this electronic measure. AIR is not responsible for any use of the Measure. AIR makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and AIR has no liability to anyone who relies on such measures or specifications. Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. AIR disclaims all liability for use or accuracy of any third-party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2023 American Medical Association. LOINC(R) is copyright 2004-2023 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2023 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2023 World Health Organization. All Rights Reserved. |
Disclaimer | The Measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Due to technical limitations, registered trademarks are indicated by (R) or [R]. |
Rationale | Multiple studies have indicated that a bone scan is not clinically necessary for staging prostate cancer in patients with a low (or very low) risk of recurrence and receiving primary therapy. For patients who are categorized as low risk, bone scans are unlikely to identify their disease. Furthermore, bone scans are not necessary for low risk patients who have no history of bony involvement or if the clinical examination suggests no bony involvement. Less than 1% of low risk patients are at risk of metastatic disease. While clinical practice guidelines do not recommend bone scans in low risk prostate cancer patients, overuse is still common. An analysis of prostate cancer patients in the Surveillance, Epidemiology and End Results Medicare database diagnosed from 2004-2007 found that 43% of patients for whom a bone scan was not recommended received it (Falchook, Hendrix, & Chen, 2015). The analysis also found that the use of bone scans in low risk patients leads to an annual cost of $4 million dollars to Medicare. The overuse of bone scan imaging for low risk prostate cancer patients is a concept included on the American Urological Association's (AUA) list in the Choosing Wisely Initiative as a means to promote adherence to evidence-based imaging practices and to reduce health care dollars wasted (AUA, 2019). This measure is intended to promote adherence to evidence-based imaging practices, lessen the financial burden of unnecessary imaging, and ultimately to improve the quality of care for prostate cancer patients in the United States. |
Clinical Recommendation Statement | For symptomatic patients and/or those with a life expectancy of greater than 5 years, bone and soft tissue imaging is appropriate for patients with unfavorable intermediate-risk, high-risk, and very-high-risk prostate cancer (National Comprehensive Cancer Network, 2024) (Evidence Level: Category 2A). Clinicians should not routinely perform abdominopelvic computed tomography (CT) scan or bone scan in asymptomatic patients with low- or intermediate-risk prostate cancer (Eastham, 2022) (Expert Opinion). Don’t perform PET, CT, and radionuclide bone scans, or newer imaging scans in the staging of early prostate cancer at low risk for metastasis (ASCO, 2021). |
Citation |
American Society of Clinical Oncology (2021) American Society of Clinical Oncology Choosing Wisely; Last Reviewed 2021. Retrieved from https://www.asco.org/news-initiatives/current-initiatives/cancer-care-initiatives/value-cancer-care/choosing-wisely |
Citation |
American Urological Association. (2013). Five Things Physicians and Patients Should Question. Choosing Wisely. https://www.auanet.org/documents/practices-resources/quality/choosing-wisely/AUA-Choosing-Wisely-15-Things.pdf |
Citation |
Eastham JA, Auffenberg GB, Barocas DA, et al. (2022) Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management. J Urol, 208(1):10-18. doi: 10.1097/JU.0000000000002757. |
Citation |
Falchook, A. D., Hendrix, L. H., & Chen, R. C. (2015). Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer. Journal of Oncology Practice, 11(2), e239-e246. doi:10.1200/jop.2014.001818 |
Citation |
National Comprehensive Cancer Network (2024) NCCN Clinical Practice Guidelines in Oncology Prostate Cancer. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf |
Definition | Bone scan: Bone scan refers to the conventional technetium-99m-methyl diphosphonate bone scan as well as 18F-sodium fluoride or prostate-specific membrane antigen (PSMA) PET/CT scan |
Definition | External beam radiotherapy : External beam radiotherapy refers to 3D conformal radiation therapy, intensity modulated radiation therapy, stereotactic body radiotherapy, and proton beam therapy |
Definition | Risk Strata: High/Very High Risk: PSA > 20 ng/mL; OR Gleason score 8 to 10/Gleason grade group 4-5; OR clinically localized stage T3 to T4 (adapted from the National Comprehensive Cancer Network, 2018) |
Definition | Risk Strata: Intermediate Risk: PSA 10 to 20 ng/mL; OR Gleason score 7/Gleason grade group 2-3; OR clinical stage T2b to T2c |
Definition | Risk Strata: Very Low/Low Risk: PSA < 10 ng/mL; AND Gleason score 6 or less/Gleason grade group 1; AND clinical stage T1 to T2a |
Guidance (Usage) | A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure. PSA test results reported in units other than ng/mL should be converted to ng/mL for reporting of this measure. In 2022, the American Urological Association published guidance recommending that clinicians not perform bone scan in asymptomatic patients with low or favorable intermediate risk prostate cancer. However, this quality measure remains focused on patients with low (or very low) risk of recurrence. This eCQM is a patient-based measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible codes. This FHIR-based measure has been derived from the QDM-based measure CMS 129v15. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core STU 6 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html). |
Measure Group (Rate) (ID: Group_1) | |
Summary | Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer |
Basis | boolean |
Scoring | [http://terminology.hl7.org/CodeSystem/measure-scoring#proportion: 'Proportion'] |
Type | [http://terminology.hl7.org/CodeSystem/measure-type#process: 'Process'] |
Improvement Notation | [http://terminology.hl7.org/CodeSystem/measure-improvement-notation#increase: 'Increased score indicates improvement'] |
Initial Population |
ID: InitialPopulation_1
Description: All patients, regardless of age, with a diagnosis of prostate cancer Logic Definition: Initial Population |
Denominator |
ID: Denominator_1
Description: Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy Logic Definition: Denominator |
Numerator |
ID: Numerator_1
Description: Patients who did not have a bone scan performed after diagnosis of prostate cancer and before the end of the measurement period Logic Definition: Numerator |
Denominator Exception |
ID: DenominatorException_1
Description: Documentation of reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, or other medical reasons) Logic Definition: Denominator Exceptions |
Supplemental Data Guidance | For every patient evaluated by this measure also identify payer, race, ethnicity and sex |
Supplemental Data Elements | |
Supplemental Data Element |
ID: sde-ethnicity
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Ethnicity Logic Definition: SDE Ethnicity |
Supplemental Data Element |
ID: sde-payer
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Payer Logic Definition: SDE Payer |
Supplemental Data Element |
ID: sde-race
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Race Logic Definition: SDE Race |
Supplemental Data Element |
ID: sde-sex
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Sex Logic Definition: SDE Sex |
Measure Logic | |
Primary Library | https://madie.cms.gov/Library/CMS129FHIRProstCaBoneScanUse |
Contents |
Population Criteria
Logic Definitions Terminology Dependencies Data Requirements |
Population Criteria | |
Measure Group (Rate) (ID: Group_1) | |
Initial Population | |
|
|
Denominator | |
|
|
Numerator | |
|
|
Denominator Exception | |
|
|
Logic Definitions | |
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: CMS129FHIRProstCaBoneScanUse |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Terminology | |
Code System |
Description: Code system SNOMEDCT
Resource: http://snomed.info/sct Canonical URL: http://snomed.info/sct |
Code System |
Description: Code system ConditionClinicalStatusCodes
Resource: http://terminology.hl7.org/CodeSystem/condition-clinical Canonical URL: http://terminology.hl7.org/CodeSystem/condition-clinical |
Code System |
Description: Code system ConditionVerificationStatusCodes
Resource: http://terminology.hl7.org/CodeSystem/condition-ver-status Canonical URL: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Code System |
Description: Code system LOINC
Resource: http://loinc.org Canonical URL: http://loinc.org |
Value Set |
Description: Value set Bone Scan
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.320 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.320 |
Value Set |
Description: Value set Prostate Cancer
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.319 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.319 |
Value Set |
Description: Value set Prostate Cancer Treatment
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.398 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.398 |
Value Set |
Description: Value set Prostate Specific Antigen Test
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.401 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.401 |
Value Set |
Description: Value set Payer Type
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Value Set |
Description: Value set Pain Warranting Further Investigation for Prostate Cancer
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451 |
Value Set |
Description: Value set Salvage Therapy
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.399 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.399 |
Direct Reference Code |
Display: Male (finding)
Code: 248153007 System: http://snomed.info/sct |
Direct Reference Code |
Display: Female (finding)
Code: 248152002 System: http://snomed.info/sct |
Direct Reference Code |
Display: Active
Code: active System: http://terminology.hl7.org/CodeSystem/condition-clinical |
Direct Reference Code |
Display: Recurrence
Code: recurrence System: http://terminology.hl7.org/CodeSystem/condition-clinical |
Direct Reference Code |
Display: Relapse
Code: relapse System: http://terminology.hl7.org/CodeSystem/condition-clinical |
Direct Reference Code |
Display: Confirmed
Code: confirmed System: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Direct Reference Code |
Display: Unconfirmed
Code: unconfirmed System: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Direct Reference Code |
Display: Provisional
Code: provisional System: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Direct Reference Code |
Display: Differential
Code: differential System: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Direct Reference Code |
Display: Tumor staging (tumor staging)
Code: 254292007 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cT1a (qualifier value)
Code: 1228892002 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cT1b (qualifier value)
Code: 1228895000 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cT1c (qualifier value)
Code: 1228899006 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cT2a (qualifier value)
Code: 1228931008 System: http://snomed.info/sct |
Direct Reference Code |
Display: Gleason score in Specimen Qualitative
Code: 35266-6 System: http://loinc.org |
Direct Reference Code |
Display: Procedure reason record (record artifact)
Code: 433611000124109 System: http://snomed.info/sct |
Dependencies | |
Dependency |
Description: QICore model information
Resource: http://hl7.org/fhir/Library/QICore-ModelInfo Canonical URL: http://hl7.org/fhir/Library/QICore-ModelInfo |
Dependency |
Description: Library SDE
Resource: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 Canonical URL: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 |
Dependency |
Description: Library FHIRHelpers
Resource: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 Canonical URL: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 |
Dependency |
Description: Library QICoreCommon
Resource: https://madie.cms.gov/Library/QICoreCommon|4.0.000 Canonical URL: https://madie.cms.gov/Library/QICoreCommon|4.0.000 |
Data Requirements | |
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient Must Support Elements: extension, birthDate, birthDate.value, url |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451 |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.319 |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-clinical-result Must Support Elements: code, effective, status, status.value, value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.320 |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-clinical-result Must Support Elements: code, value, effective, status, status.value Code Filter(s): Path: code Code(s): http://snomed.info/sct#254292007: 'Tumor staging (tumor staging)' |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-clinical-result Must Support Elements: code, effective, status, status.value, value Code Filter(s): Path: code Code(s): http://loinc.org#35266-6: 'Gleason score in Specimen Qualitative' |
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.398 |
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.399 |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-lab Must Support Elements: code, effective, status, status.value, value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.401 |
Data Requirement |
Type: Coverage
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage Must Support Elements: type, period Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451 |
Generated using version 0.4.8 of the sample-content-ig Liquid templates |